team dermgerm
play

Team DermGerm Freer D 1 , Jacus M 1 , Kita S 1 , Sawlani S 1 , Waters S 1 , Campbell K 2 , Dash S 2 , Huang W 2 , Padinjarekutt S 3 1 Dept. of Bioengineering, 2 Dept. of Biology, 3 Dept. of Chemistry University of Pittsburgh Im Immunologists Bio

0 downloads 5 Views 3,1 MB Size Report
  1. Team DermGerm Freer D 1 , Jacus M 1 , Kita S 1 , Sawlani S 1 , Waters S 1 , Campbell K 2 , Dash S 2 , Huang W 2 , Padinjarekutt S 3 1 Dept. of Bioengineering, 2 Dept. of Biology, 3 Dept. of Chemistry University of Pittsburgh

  2. Im Immunologists Bio ioengineers Derm rmatolo logists Bio iolo logists Computer Chemists Sci cientists WHO WE ARE

  3. Develo lop Immunologists Im Bio ioengineers Derm rmatolo logists Skin in Bio iolo logists Computer Chemists Pro robio ioti tics Sci cientists WHO WE ARE

  4. Protect against sun damage Remove pathogens Balance skin oils

  5. PROPIONIBACTERIUM ACNES Presence of P. acnes Commensal skin bacteria associated with acne

  6. Modeling Transformation Probiotic Functions Human Practices

  7. Modeling Transformation Probiotic Functions Human Practices

  8. CHALLENGES Gram negative  thick cell wall Restriction modification system Growth time - 5 days Anaerobic growth $100-200 $5

  9. P. ACNES TRANSFORMATION Transformation Protocol: Cheong et al, 2008 Erm Goal: Transform P. Acnes using electroporation protocols

  10. Design of Experiments (DOX) • Choose trials carefully for statistical advantage • Reveals which parameters have most effect on successful transformation Parameters: - P. acnes strain - Culture temperature 16 - Amount of glycine trials - Lysozyme concentration instead - Restriction enzyme of 256 inhibitor - Amount of plasmid DNA - Electric field strength - Incubation temperature

  11. RESULTS 1 No growth after electroporation. 2 Growth resembling P. acnes , but failed PCR validation. 3 Growth does not resemble P. acnes.

  12. DISCUSSION • Have not yet been able to transform any P. acnes • Different strains • Parameters  extreme conditions • Activity of non-type I restriction systems

  13. FUTURE DIRECTIONS Attempt New S. Aureus Species 1. Broad Skin Location S. epidermidis 2. Transformation Protocols M. lysodeikticus Available

  14. Modeling Transformation Probiotic Functions Human Practices

  15. HSP60 Promoter Melanin Desaturase Cathelicidin

  16. HSP60 PROMOTER Strong promoter from 7 1 2 3 4 5 6 Mycobacterium bovis 20 0 kb kb • Works well in other .5 .5 kb kb propionibacteria Figure 1. Gel electrophoresis showing presence of HSP60 Hsp60 mRFP1 after PCR. Lanes 2 - 4 contain hsp60 promoter. Lanes 6 - 7 contain hsp60 promoter with an RBS Hsp60 RBS mRFP1 Part:BBa_K1548000 Part:BBa_K1548001

  17. HSP60 PROMOTER Testing in E. coli 1.78E+05 Not functional 1.76E+05 u) (au) 1.74E+05 Fluoresence (a 1.72E+05 As predicted by 1.70E+05 1.68E+05 BPROM 1.66E+05 RFP! Fl 1.64E+05 1.62E+05 mRF 1.60E+05 1.58E+05 Characterized part to be 1.56E+05 Hsp60-RBS-mRFP1 Hsp60-alo lone non-functional as expected Cons nstruct

  18. MELANIN Goal: Insert MelA into P. acnes to produce melanin Part:BBa_K274001 – Cambridge ‘09

  19. MELANIN 4 2 3 5 1 Vector Backbone 3,000 bp 2,000 bp Expected MelA Goal: Insert MelA into P. acnes to Figure 2. Gel electrophoresis showing melanin digestion with produce melanin XbaI and PstI Lanes 2 & 4 contain melanin and vector backbone. Part:BBa_K274001 – Cambridge ‘09

  20. CATHELICIDIN Goal: Activate controlled cathelicidin production under blue light • Dependent on P. acnes population

  21. CATHELICIDIN 1 2 3 4 3 kb 1.5 kb YF1 FixK2 Cath T1 Hsp60 YF1 FixJ Figure 3. Gel electrophoresis showing cathelicidin system. Lane 2 contains the Blue Promoter – Part:BBa_K1548002 Part:BBa_K1548003 mRFP1 – Cathelicidin part (~1100 bp).

  22. DESATURASE Oleic Acid Δ 12 12-FAD Linoleic Acid Goal: Produce desaturase to restore the natural lipid composition of skin

  23. DESATURASE Oleic Acid Δ 12 12-FAD Linoleic Acid Goal: Produce desaturase to restore the natural lipid composition of skin

  24. DESATURASE Hsp60 RBS mRFP1 Desaturase Terminator Desaturase digestion with EcoRI & SpeI mRFP1 digestion with EcoRI & XbaI Desaturase Vector Backbone 3,000 bp Linearized 1,000 bp mRFP1 and Vector Desaturase Part Backbone

  25. FUTURE VALIDATION MELANIN • Visual inspection

  26. FUTURE VALIDATION MELANIN CATHELICIDIN • • Visual inspection Viability assay under blue-light

  27. FUTURE VALIDATION MELANIN CATHELICIDIN DESATURASE • • • Visual inspection Viability assay Colorimetric assay under blue-light for oleic acid

  28. SAFETY Safety • P. acnes naturally occurs deep in human skin • Cathelicidin is natural kill switch

  29. SAFETY Safety • P. acnes naturally occurs deep in human skin • Cathelicidin is natural kill switch • Could add genetic fence:

  30. Modeling Transformation Probiotic Functions Human Practices

  31. CATHELICIDIN MODEL Cathelicidin

  32. CATHELICIDIN MODEL Bacteriocidal Cathelicidin

  33. CATHELICIDIN MODEL Bacteriocidal Pro-Inflammatory Cathelicidin

  34. BOOLEAN NETWORKS Model Biological Circuits as Digital Circuits

  35. Normal Input Network Diagram

  36. Normal Input Output Output Network Diagram

  37. Cathelicidin Input Topical Application Network Diagram

  38. Cathelicidin Input Output Topical Application Output Network Diagram

  39. Norm rmal l Topical l Node Condit itions Cath theli licidin Cathelicidin 23% 35% P. acnes 44% 37% Immune Response 21% 28% (Inflammation) Injury 52% 42% (Inflammation) Ave vera rage In Infl flammation 37% 37% 35% 35% (Immune + Injury)

  40. Norm rmal l Topical l Node Condit itions Cath theli licidin Cathelicidin 23% 35% Lower growth P. acnes 44% 37% of P. acnes Immune Response 21% 28% Similar (Inflammation) average Injury 52% 42% inflammation (Inflammation) Ave vera rage In Infl flammation 37% 37% 35% 35% (Immune + Injury)

  41. Injury Node Average 1.0 Normal Conditions 0.9 Topical Cathelicidin 0.8 0.7 Avg State 0.6 0.5 0.4 0.3 0.2 0.1 0.0 1 3 5 7 9 11 13 15 17 19 21 23 25 Update Round

  42. Modeling Transformation Probiotic Functions Human Practices

  43. EDUCATE Ethics Research Forum Dr. Albert Kligman and Holmesburg Prison Experiments Promoted and encouraged the study of ethics in synthetic biology

  44. EDUCATE SciencePalooza “ Dermalicious ” Mobile Science Lab “Enzyme Time”

  45. ENGAGE

  46. ENGAGE Wordpress Blog: http://igempitt.wordpress.com Professional consults How-to articles Team videos

  47. COLLABORATIONS Montgomery HS Pittsburgh Meetup Virginia Survey

  48. ACKNOWLEDGEMENTS Advi visors Gra raphic ic Art rts Jas ason Lo Lohmuelle ler – Te Team Mentor, MVP Ryan Blac ack - Butt tton Mak aker, r, Extr traordin inaire re Graham Hat atfull ll – Principal l In Inve vestigator Cat atherine Kit ita - Graphic Des esigner r Lance Dav La avid idson – Clu lub Advi visor Meli lissa Th Thompson – Graphic Desig igner Nat atasa Mis iskov-Ziv ivanov - Computer Sim imula latio ion Advi visor Anan and Mah ahali lingam – Vid ideographer Sponsors – Univ iversit ity of f Pit ittsburgh Admin inistra rativ ive Support – Univ iversity of f Pit ittsburgh San anjeev Shroff – Chair of Bio ioen engin ineering Dep epartment John Pat atzer – Bio ioen engineering Professor Pau aula la Grabowski i – Chair of f Bio iolo logy Dep epartment Alic icia Wel elsh – Bio ioen engineering Admin inistrator Dav avid Vorp rp – Ass ssociate Dea ean of f Researc rch fo for r Pat atri ricia ia Dea ean – Bio iolo logy Admin inistrator Swanson School l of f Engineerin ing Pat atri rick Mull llen – Dea ean of f Undergraduate Research fo for Amie ie DiT iTomasso – Sci cience Outreach Coordinator Die ietrich Sch chool l of f Arts an and Sci ciences Nic icki i Zev evola la – CEO & Founder, FutureDerm Sponsors – Oth ther Joseph Ayo yoob – Program Dir irector, TE TECBio REU Experiment.com te team am – Crowdfundin ing Platform rm Pau aul l Kova vach – Dire irector of f Mark rketing an and Communications Laboratory Support La Car arlos Guerrero – Graduate Student, Hat atfull Lab Lab Andre rew Fal alk – Exec ecutiv ive Dire irector r of f Corp rporate & & Chin ing-Chung Ko Ko – Graduate Stu tudent t Hat atfull ll Lab Lab Foundation Rel elations Sak Kia ia Goh – Graduate Stu tudent, Bio ioengineerin ing

  49. pBRES36a 1 2 3 4 5 6 Lane La Reaction Re 1 1 kb Marker 2 Plasmid + XbaI 10 kb 10 kb 3 Plasmid + PstI 3 kb kb 4 Plasmid + SpeI 5 Plasmid +EcoRI Plasmid +SpeI and 6 EcoRI 1 1 kb kb

  50. BUILDING THE MODEL Random Literature Starting Searches Conditions Network Diagram Stochastic Av Average Updates 1,0 ,000 Tria ials Boolean Rules Construction Simulation

  51. BUILDING THE MODEL Random Literature Starting Searches Conditions Network Diagram Stochastic Av Average Updates 1,0 ,000 Tria ials Boolean Rules Construction Simulation

  52. BUILDING THE MODEL Random Literature Starting Searches Conditions Network Diagram Stochastic Av Average Updates 1,0 ,000 Tria ials Boolean Rules Construction Simulation

Recommend Documents


pawel k olszewski phd
Pawel K. Olszewski, PhD

Pawel K. Olszewski, PhD pawel@waikato.ac.nz TEAM TEAM TEAM TEAM TEAM

di team managers we need you
DI - TEAM MANAGERS WE NEED YOU!!!!!

DI - TEAM MANAGERS WE NEED YOU!!!!! What does it mean to be a t team manager

great writers read
Great Writers Read Week 2 - Day 1

Great Writers Read Week 2 - Day 1 Lets get into teams TEAM 1 TEAM 2 TEAM 3

team discussion process and formalities
Team discussion: Process and

Team discussion: Process and formalities The supervisor provides team results

characteristics of an e ffective team
Characteristics of an E ffective Team

Agenda Characteristics of an E ffective Team Team Simulation What is a

building a caregiving team
BUILDING A CAREGIVING TEAM Lessons

BUILDING A CAREGIVING TEAM Lessons Learned Team Structure Team Member Team

building the perfect team definition of a team a team is
Building the Perfect Team Definition of

Building the Perfect Team Definition of a Team A team is a relatively sm all

building a team process description
BUILDING A TEAM Process description

BUILDING A TEAM Process description TEAM BUILDING TEAM CONSOLIDATION (The

environment climate change team number 3
Environment & Climate Change - Team

Environment & Climate Change - Team Number: 3 The Team Members: Name

the power of the team
The Power of The Team With The Zac

The Power of The Team With The Zac Team, you dont just get an Zac Pasmanick

the stress detox
THE STRESS DETOX : TAKE BACK CONTROL

THE STRESS DETOX : TAKE BACK CONTROL OF YOUR LIFE GET TO KNOW YOUR STRESS ON

jak inhibitor ctp 543 achieves primary endpoint in phase
JAK Inhibitor CTP-543 Achieves Primary

American Academy of Dermatology Annual Meeting March 2, 2019 JAK Inhibitor

microrna systems biology
microRNA Systems Biology miRagen

Harnessing the Power of microRNA Systems Biology miRagen Therapeutics

sonoma pharmaceuticals
SONOMA PHARMACEUTICALS RESULTS FOR THE

SONOMA PHARMACEUTICALS RESULTS FOR THE QUARTER ENDING 30 JUNE 2018 August 8,

greg gubitz ceo gilbert godin president amp coo
Greg Gubitz | CEO Gilbert Godin |

Investor Presentation Greg Gubitz | CEO Gilbert Godin | President & COO

hair are
HAIR ARE TM PROFESSIONAL Easy Long

HAIR ARE TM PROFESSIONAL Easy Long Term Hair Removal System This system

national birth defect registry
National Birth Defect Registry Based

National Birth Defect Registry Based on concept of alert practitioner

presentations in primary care rob danoff do ms facofp
+ Presentations in Primary Care Rob

A Colorful Tour of Dermatologic + Presentations in Primary Care Rob Danoff

public hearing
Public Hearing Wayne Disposal, Inc.

7/23/2018 Public Hearing Wayne Disposal, Inc. Hazardous Waste Landfill

opp day q3 2018
Opp Day Q3 2018 Information as of 3Q18

Opp Day Q3 2018 Information as of 3Q18 Latest update on 26 th Nov 2018 2

corporate presentation
Corporate Presentation April 2019

Corporate Presentation April 2019 TSXV | NHP - A GROWTH STORY > Mondias

laura roche rd
Laura Roche RD Horizon Health

Laura Roche RD Horizon Health Authority May 29, 2018 AGENDA History of the